share_log

4: Statement of changes in beneficial ownership of securities-Director Charles Faith L.

SEC ·  Nov 21, 2024 05:33

Summary by Moomoo AI

Charles Faith L., reported a significant acquisition of shares in Conduit Pharmaceuticals (CDT.US) on November 18, 2024. The transaction involved the purchase of 75,000 shares of common stock, followed by an additional 266,594 shares at a price of $0.0919 per share. Following these transactions, Charles Faith L. now directly holds a total of 341,594 shares in the company. The transactions were classified as grants, awards, or other acquisitions, and have been completed as of the reported date.
Charles Faith L., reported a significant acquisition of shares in Conduit Pharmaceuticals (CDT.US) on November 18, 2024. The transaction involved the purchase of 75,000 shares of common stock, followed by an additional 266,594 shares at a price of $0.0919 per share. Following these transactions, Charles Faith L. now directly holds a total of 341,594 shares in the company. The transactions were classified as grants, awards, or other acquisitions, and have been completed as of the reported date.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more